Delivery Order SPE2DR25D1053-SPE2DR26FT106
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. The place of performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of XDEMVY 0.25% DROP 10ML pharmaceutical product. This firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by October 16, 2025. The contract is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters, and does not utilize a set-aside designation. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of XDEMVY 0.25% drop in 10ml units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The order is scheduled for completion by November 10, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $1,223.59, was awarded on July 23, 2025, to AmerisourceBergen Drug Corp for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. The contract represents a firm fixed price delivery order under a competitive, non-set-aside procurement process. Performance will be completed by August 13, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters. The Defense Logistics Agency, through...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical supplies, specifically XDEMVY 0.25% Drop in 10ml units. This firm fixed-price delivery order, valued at $3,670.77, represents a non-set-aside competitive award with a completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product. This firm fixed-price delivery order, valued at $1,223.59, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of XDEMVY 0.25% drop in 10ml quantities, with a ceiling value of $1,223.59 and a firm fixed price structure. This non-set-aside competitive award is categorized as a delivery order with an ultimate completion date of September 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT106Delivery Order
This delivery order, issued on October 20, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $1,184.60 for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product, with completion targeted for November 10, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense responsible for supply chain management and logistics support to military healthcare systems. The performance location is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this competitive award. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This prime vendor agreement serves as a comprehensive vehicle enabling AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The underlying IDC structure allows for flexible ordering of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to meet evolving federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/20/25 |